WEKO3
アイテム
No inhibitory effect on P-glycoprotein function at blood-brain barrier by clinical dose of clarithromycin: a human PET study with [11C]verapamil
https://repo.qst.go.jp/records/45769
https://repo.qst.go.jp/records/45769c540bbd5-e13a-4ca3-882d-cb18158d7fde
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-03-19 | |||||
タイトル | ||||||
タイトル | No inhibitory effect on P-glycoprotein function at blood-brain barrier by clinical dose of clarithromycin: a human PET study with [11C]verapamil | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Arakawa, Ryosuke
× Arakawa, Ryosuke× Ito, Hiroshi× Okumura, Masaki× Morimoto, Takuya× Seki, Chie× Takahashi, Hidehiko× Takano, Akihiro× Suhara, Tetsuya× 荒川 亮介× 伊藤 浩× 奥村 正紀× 森本 卓哉× 関 千江× 高橋 英彦× 高野 晶寛× 須原 哲也 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | To investigate the effects of the clinical dose of clarithromycin, a substrate of P-glycoprotein (P-gp), on P-gp function using positron emission tomography (PET) with [(11)C]verapamil. METHODS: Two PET scanning with [(11)C]verapamil were performed before and after administration of 400 mg/day of clarithromycin on each of four healthy male subjects. The rate constant of transfer from plasma to brain (K (1)) was estimated by integration plot method. RESULTS: K (1) values of [(11)C]verapamil before administration of clarithromycin were 0.042-0.070 mL/cm(3)/min (0.054 +/- 0.012) and those after administration were 0.037-0.066 mL/cm(3)/min (0.055 +/- 0.013). No significant change in K (1) values of [(11)C]verapamil was observed between before and after administration of clarithromycin (P = 0.85). CONCLUSION: K (1) values of [(11)C]verapamil were not changed by clinical dose administration of clarithromycin, suggesting that a clinical dose of clarithromycin does not affect P-gp function at the blood-brain barrier. | |||||
書誌情報 |
Annals of Nuclear Medicine 巻 24, 号 2, p. 83-87, 発行日 2010-02 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0914-7187 |